Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment
Recruiting · NCT07711171 · Registry updated 2026-07-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Canagliflozin in the Treatment of Type 2 Diabetes With Mild Cognitive Impairment | Cognition Disorders, Cognitive Dysfunction, Nutritional and Metabolic Diseases, cognitive disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, psychiatric disorder, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-07-17 | NCT07711171 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fudan University | 653 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fudan University affiliated Huadong Hospital | Shanghai | China | 2 |